SCHEMBL503294

SCHEMBL503294

C=C(C)C(=O)NOC(=O)C(=C)C

nearest known ligand 0.52

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.52
TDP1 Q9NUW8 2/20 0.39
TSHR P16473 3/20 0.37
THRB P10828 1/20 0.34
TGFBR1 P36897 1/20 0.33
KDM4E B2RXH2 1/20 0.32
HSD17B10 Q99714 1/20 0.31
RXFP1 Q9HBX9 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8981771 1.00 ALDH1A1 (0.52) ALDH1A1TDP1TSHRTHRBTGFBR1
Acetone SCHEMBL27591806 0.98 ALDH1A1 (0.50) ALDH1A1TDP1TSHRTHRBTGFBR1
SCHEMBL27851518 0.92 ALDH1A1 (0.48) ALDH1A1TDP1TSHRTHRBTGFBR1
SCHEMBL27851519 0.86 ALDH1A1 (0.42) ALDH1A1TDP1TSHRTGFBR1KDM4E
SCHEMBL9846986 0.82 ALDH1A1 (0.42) ALDH1A1TDP1TSHRTGFBR1KDM4E
SCHEMBL16376102 0.82 ALDH1A1 (0.55) ALDH1A1TDP1TSHRTHRBTGFBR1
SCHEMBL27680455 0.82 ALDH1A1 (0.42) ALDH1A1TDP1TGFBR1KDM4EHSD17B10
SCHEMBL1115358 0.82 ALDH1A1 (0.55) ALDH1A1TDP1TSHRTHRBKDM4E
SCHEMBL3748063 0.80 ALDH1A1 (0.52) ALDH1A1TDP1TSHRTHRBHSD17B10
SCHEMBL94516 0.80 ALDH1A1 (0.52) ALDH1A1TDP1TSHRTHRBHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 103 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9452218-B2 Compositions and methods for delivery of kinase inhibiting peptides PURDUE RESEARCH FOUNDATION (US) 2016-09-27 US claimed
US-9358211-B2 Stealth polymeric particles for delivery of bioactive or diagnostic agents HOWARD UNIVERSITY (US) 2016-06-07 US claimed
EP-2598599-B1 STIMULI-RESPONSIVE HIGH VISCOSITY PILL HALLIBURTON ENERGY SERVICES INC (US) 2015-06-17 EP claimed
US-8921429-B2 Biodegradable stealth polymeric particles fabricated using the macromonomer approach by free radical dispersion polymerization HOWARD UNIVERSITY (US) 2014-12-30 US claimed
US-20140274929-A1 Stealth Polymeric Particles For Delivery Of Bioactive Or Diagnostic Agents HOWARD UNIVERSITY (US) 2014-09-18 US claimed
US-8772355-B2 Stealth polymeric particles for delivery of bioactive or diagnostic agents HOWARD UNIVERSITY (US) 2014-07-08 US claimed
EP-2643372-A2 STEALTH POLYMERIC PARTICLES FOR DELIVERY OF BIOACTIVE OR DIAGNOSTIC AGENTS Howard University (US) 2013-10-02 EP claimed
WO-2013134636-A1 COMPOSITIONS AND METHODS FOR DELIVERY OF KINASE INHIBITING PEPTIDES PURDUE RESEARCH FOUNDATION (US) 2013-09-12 WO claimed
US-8418761-B2 Stimuli-responsive high viscosity pill HALLIBURTON ENERGY SERVICES, INC. (US) 2013-04-16 US claimed
WO-2012071452-A2 STEALTH POLYMERIC PARTICLES FOR DELIVERY OF BIOACTIVE OR DIAGNOSTIC AGENTS HOWARD UNIVERSITY (US) 2012-05-31 WO claimed
US-20120129797-A1 BIODEGRADABLE STEALTH POLYMERIC PARTICLES FABRICATED USING THE MACROMONOMER APPROACH BY FREE RADICAL DISPERSION POLYMERIZATION NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2012-05-24 US claimed
US-20120129798-A1 STEALTH POLYMERIC PARTICLES FOR DELIVERY OF BIOACTIVE OR DIAGNOSTIC AGENTS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2012-05-24 US claimed
US-20120024529-A1 Stimuli-Responsive High Viscosity Pill HALLIBURTON ENERGY SERVICES, INC. 2012-02-02 US claimed
EP-0434438-B1 Hydrolytically degradable hydrophilic gels and the method for preparation thereof CESKE AKADEMIE VED (CZ) 1996-05-01 EP claimed
US-5130479-A Compounds for forming polymers for use in medical equipment, membranes, contact lenses and for ultra filtration CESKOSLOVENSKA AKADEMIE VED (CS) 1992-07-14 US claimed
US-5124421-A Addition polymers crosslinked with N,O-dimethacryloylhydroxylamine; oral drug delivery; sustained release in the duodenum CESKOSLOVENSKA AKADEMIE VED (CS) 1992-06-23 US claimed
EP-0434438-A2 Hydrolytically degradable hydrophilic gels and the method for preparation thereof AKADEMIE VED CESKE REPUBLIKY (CZ) 1991-06-26 EP claimed
JP-10072427-A None JP disclosed
EP-0434438-A2 Hydrolytically degradable hydrophilic gels and the method for preparation thereof AKADEMIE VED CESKE REPUBLIKY (CZ) 1991-06-26 EP disclosed
EP-0434438-A2 Hydrolytically degradable hydrophilic gels and the method for preparation thereof AKADEMIE VED CESKE REPUBLIKY (CZ) 1991-06-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120129798-A1 STEALTH POLYMERIC PARTICLES FOR DELIVERY OF BIOACTIVE OR DIAGNOSTIC AGENTS SSTR5, SSTR3, SSTR1 ALDH1A1 528/4885TDP1 2996/4885TSHR 2058/4885
US-20120129797-A1 BIODEGRADABLE STEALTH POLYMERIC PARTICLES FABRICATED USING THE MACROMONOMER APPROACH BY FREE RADICAL DISPERSION POLYMERIZATION LDHA, LDHB, ALDH2 ALDH1A1 6/4885TDP1 2695/4885TSHR 4355/4885
US-20140274929-A1 Stealth Polymeric Particles For Delivery Of Bioactive Or Diagnostic Agents SSTR5, PLA2G3, SSTR3 ALDH1A1 811/4885TDP1 3278/4885TSHR 1987/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.